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Abstract
Glaucoma unresponsive to medical treatment is managed by 
surgery. Augmentation with mitomycin C (MMC) is considered 
in patients at high risk of surgery failure. 
Aim: In this paper we assess and compare the success and 
complications of this procedure performed in the local state 
hospital with those of larger international centres. 
Methods: A retrospective study, of the surgery performed 
between 2003 and 2007 at St. Luke’s Hospital by one surgeon 
(FM), was conducted. The total number of eyes considered in 
this analysis was 32. Intraocular pressures and complications 
up to one year post-operatively were recorded.
Results: The mean intraocular pressure decreased from 
30mmHg pre-operatively to 18mmHg post-operatively. 
The mean IOP drop registered was 42%. Of the 32 eyes that 
underwent trabeculectomy augmented with MMC, 23 were 
classified as a complete success with IOP remaining below 
21mmHg at 1year post-surgery. Six eyes were considered as a 
partial success since they had an IOP under 21mmHg but this had 
to be kept under control with the administration of medications. 
Failure of surgery was classified as uncontrollable IOP, although 
also on medications. This was seen in 3 eyes. Using the central 
limit theorem, the significance of the difference in means and 
difference in percentages of IOP drop and complication rates, 
between the local state hospital procedures and international 
centres, were calculated. 
Conclusion: Incidences obtained from this analysis 
compare very favourably with results from international studies, 
showing no significant differences.
Gabriella Sciriha, Franco Mercieca
Original Article
Success and complication rates of 
trabeculectomies augmented with MMC 
in the management of glaucoma
Gabriella Sciriha MD*
Department of Ophthalmology, Mater Dei Hospital, Msida, Malta
Email: gabysci@yahoo.com
Franco Mercieca MD, FRCOphth
Department of Ophthalmology, Mater Dei Hospital, Msida, Malta
Keywords
Glaucoma, mitomycin C, trabeculectomy, intraocular 
pressure
* corresponding author
Glaucoma can be defined as a pathologic condition in which 
there is progressive loss of ganglion cell axons causing visual 
field damage that is related to intraocular pressure (IOP).1 
Trabeculectomy, first introduced by Cairns in 1968, is by far 
the most common type of glaucoma filtering surgery used in 
the management of glaucoma when medical treatment fails. 
However in high risk groups such as in young individuals, 
patients suffering from neovascular glaucoma, uveitic glaucoma 
and steroid induced glaucoma as well as in patients on 
previous prolonged medical treatment, there is a higher risk of 
scarring response at the surgical site resulting in failure of the 
trabeculectomy.
Therefore in such high risk glaucoma patients, modulation 
of wound healing would potentially increase the success 
rate of the trabeculectomy. Mitomycin C, an antitumour 
medication, inhibits DNA synthesis and thus suppresses cell 
proliferation. In glaucoma surgery it has been shown to inhibit 
fibroblast proliferation, thus preventing scarring with better 
surgical outcomes. These results however have been marred 
by complications which vary from mild, such as corneal 
erosions and bleb leaks, to severe, as for instance hypotonic 
maculopathy longstanding choroidal detachments, late bleb 
leaks and endophthalmitis. Recent procedures being used 
in the management of glaucoma include deep sclerotomy, 
viscocanalostomy and canaloplasty. Reports on results of these 
procedures have shown a low percentage of complications. 
However these procedures are time consuming and require 
significant mastering of complex new skills. In this paper we 
analysed the effectiveness and complications of patients who 
underwent trabeculectomy augmented with mitomycin and 
compared them to peer studies.
Method
A retrospective study was conducted in which we retrieved 
the records of all the patients that underwent MMC augmented 
trabeculectomy, between January 2003 and December 
2007. This procedure was carried out on a total of 36 eyes. 
All operations were performed at the Eye Unit in St Luke’s 
Hospital, Malta, by one ophthalmologist (FM). Out of the 36 
interventions, 4 had incomplete pre or post-operative data and 
therefore they were not included in this study. All information 
retrieved was divided into pre-operative, intra-operative and 
postoperative data.
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Verbal consent was obtained from the patients whose 
information was included in this study. No reference to any 
particular patient is made in this analysis.
Pre-operative
Demographic data including gender, age and race, as well 
as the duration and number of antiglaucoma medications every 
patient was on were recorded. Further information was obtained 
from records of the last pre-operative visit. These included the 
best corrected visual acuity, aetiology of glaucoma diagnosed by 
using biomicroscopy, intraocular pressure measurements using 
a Goldmann applanation tonometer and optic disc appearance 
using indirect ophthalmoscopy.  
Operative technique
A fornix based conjuntival flap was fashioned and the sub 
Tenon’s space dissected posteriorly alongside the length of the 
superior rectus. No fixation suture was used.
A partial thickness 2 X 3mm rectangular scleral flap 
was created. A pledget of cellulose sponge soaked in 0.04% 
Mitomycin C solution was then placed under the Tenon’s 
capsule, also overlying the base of the scleral flap and left there 
for 2 to 2 and a half minutes. Care was taken so that the edges of 
the conjunctival flap were not exposed to the drug. The sponge 
was then removed and the space between the conjunctiva and 
episclera was thoroughly irrigated with saline.
The anterior chamber was subsequently entered and a 
sclerotomy using Kelly’s punch was performed. This was followed 
by a guarded peripheral iridectomy. A 1.5mm paracentesis was 
also prepared. The scleral flap was then re-approximated with 
two interrupted 10-0 nylon sutures (Ethicon) with slightly 
greater tension than a standard trabeculectomy. At this point 
the paracentesis was used to verify that the anterior chamber 
can be maintained without a risk of overfiltration. The Tenon’s 
capsule and conjunctiva were then sutured with two interrupted 
10-0 nylon sutures to the limbus. A subconjuctival injection of 
methylprednisolone acetate and ceftriaxone was administered 
in the inferior fornix.
Post-operative care
All patients received a standard regimen of dexamethasone 
and gentamicin eye drops six hourly. The antibiotic was usually 
stopped after 2 to 3 weeks but the steroid was tailed off over 
the subsequent 2 to 3 months. Topical mydriatics were only 
used in cases where the patient developed a shallow anterior 
chamber post operatively to prevent aqueous misdirection 
syndrome and posterior iris synechiae. Data recorded at follow-
up examinations that included IOP measurements as well as 
any complications that developed at 1 day, 1 week, 3 weeks, 
3 months, 6 months and 1 year post-operatively were available. 
The need for post-operative medical glaucoma treatment or the 
need for re-operation was also noted.
Results
Gender and causes of glaucoma
The patients operated upon were all Caucasians. The gender 
distribution of patients’ eyes that underwent this procedure 
was predominantly male at 56.3% to 43.7%. The frequency in 
the various age groups is given in Table 1. Figure 1 shows the 
distribution of the causes of glaucoma operated upon.
 
Pre-operative IOP and antiglaucoma treatment
All the patients operated were on full anti glaucoma 
treatment (AGT) prior to surgery. Some patients could not be 
treated with the customary three IOP lowering eye drops due 
to hypersensitivity reactions, cardiac failure, asthma, or severe 
depression, the latter three being contraindications for the use of 
beta blockers. Others should not be treated with acetazolamide 
since they had allergies to sulfa drugs, significant liver and kidney 
disease, adrenal gland failure (Addison’s disease), or developed 
severe side effects including lethargy, depression, confusion, 
toxic epidermal necrolysis, photosensitivity reactions, urticaria, 
thrombotic thrombocytopaenic purpura, nausea, vomiting and 
hypokalaemia. 
The patients operated upon were on the pre-operative 
antiglaucoma treatment shown in Figure 2.
Figure 3 shows the distribution of pre-op IOP with the mean 
pre-operative IOP being 30mmHg.
Table 1: Frequency of operated patients according to 
different age groups
Age groups Number of patients
10-20 2
21-30 0
31-40 3
41-50 6
51-60 8
61-70 6
71-80 7
Figure 1: Causes of glaucoma for which operations were 
performed
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Outcome of surgery
Early post-operative IOP and IOP one year post-op are 
shown in Figure 4 and 5 respectively.
The mean post-operative IOP one year after surgery 
stabilized at 18mmHg. There was a drop in IOP in 29 of the 32 
eyes operated upon.
Figure 6 depicts the percentage IOP drop in the 29 eyes that 
registered a drop in IOP post-op. The mean IOP drop registered 
was 42%.
The surgeries performed were considered a complete success 
if the IOP was stabilized below 21mmHg and no deterioration 
in visual fields and optic nerve appearance was recorded. 
There were no patients with a post-operative IOP of less than 
21mmHg that recorded deterioration in visual fields or further 
optic nerve damage. Partial success surgery was considered 
as having an IOP under 21mmHg (together with stable visual 
fields results and optic nerve appearance) kept under control 
with the administration of medications. Failure of surgery was 
classified as uncontrollable IOP, although also on medications, 
together with progressive nerve damage and glaucomatous 
visual field defects. Hypotony was defined as IOP of less than 
8mmHg documented at 2 early post-operative visits. Table 2 
summarises the results obtained.
Complications
The main complication associated with the use of MMC in 
trabeculectomy is the development of cystic thin-walled blebs 
that predispose to chronic hypotony, late-onset bleb leak and 
endophthalmitis.
Nine of the eyes operated upon had an excessive drop in 
IOP. Of these, eight suffered from early hypotonicity and the 
other suffered from late hypotonicity. Three of the eyes got 
hypotonic maculopathy due to an excessively low IOP. Two 
patients underwent further surgery since the IOP failed to 
stabilise. In both these patients autologous blood injection and 
subsequent refashioning of the bleb had to be carried out, both 
with good end IOP control.
The desired reduction in IOP failed for three eyes. All these 
patients were rubeotic glaucoma patients. One had pre-op 
bullous keratopathy and the aim of the operation in this case 
was to decrease the IOP to gain some pain relief. An increase 
in IOP by 14% was registered. Another patient developed a 
Table 2: Surgery success rates
Complete success IOP <=21mmHg 23 eyes
Partial success: 
controlled  On 1 AGT drops 3 eyes
  On 2 AGT drops 1 eye
  On 3 AGT drops 1 eye
  On 3 AGT drops 
 + acetazolamide PO 1 eye
Failure On full AGT 
 and still not controlled 3 eyes
Figure 2: Pre-operative anti-glaucoma treatment
Figure 3: Distribution of pre-operative intra-ocular 
pressure
severe hyphaema and as a result, the IOP post-op remained 
the same as the pre-op IOP. The third patient underwent repeat 
trabeculectomy augmented with MMC and the IOP went down 
by 40.7% after this second operation.
A break down of the complication rates (Figure 7) shows 
that early hypotonicity is predominant, followed by hyphaema. 
No cases of blebitis or endophthalmitis were reported, however 
a lifetime risk of blebitis remains especially for those patients 
with cystic blebs.
It is worth noting that three of the thirty two eyes had 
undergone surgical trabeculectomy before trabeculectomy 
augmented with MMC was carried out. In the early post-op 
phase, thirteen had to perform regular ocular massage for proper 
filtration and bleb formation and eight eyes underwent laser 
suture lysis for control of IOP. Worst IOP control and highest 
complication rates occurred in rubeotic eyes. 
The operations carried out in which the IOP failed to decrease 
sufficiently even after administering medical treatment were all 
for rubeotic glaucoma. One achieved a good decrease in IOP but 
the final IOP was still high at more than 21mmHg. The other 
patient had pre-op decompensating bullous keratopathy. 
Comparison of results
The above results were compared with other studies carried 
out in specialized centres and the significance of the difference 
in means and of the difference in proportions, depending on the 
information available from the other studies, was calculated. 
(Table 3).
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Table 4: Comparison of local results to published data
Compared studies  t (audit) 5% significant  t table Degrees of freedom
Mercieca : Zacharia Mean IOP drop 0.248 2.047 28
Mercieca : Casson Mean IOP postop 0.259 2.04 31
Table 3: Comparison of local results to published data
 Compared study Local study Total no. of eyes Total no. of eyes
   of compared study  of local study
Mean IOP drop Zacharia: 12.3 mmHg 12.88mmHg 52 29*
Mean IOP post-op Casson: 14 mmHg 18mmHg 21 32
Hypotonicity Hyung: 30 eyes  8 eyes 117 32
Hypotonicity Zacharia: 17 eyes  8 eyes 52 32
Maculopathy Hyung: 11 eyes  3 eyes 117 32
IOP <21mmHg Megevand: 22 eyes  
 (in the 2min exposure 
 to MMC group) 23 eyes 25 32
* There was a drop in IOP in 29 of the 32 eyes operated upon. 
Only these were considered in the calculation of the mean IOP drop
The significance of difference in means
Using the Central Limit Theorem, the t-statistic, 
approaches the 0+/-1 normal distribution with variance, 
where the variance (var) is the square of the standard 
deviation,
n1 = no. of patients in this study,
n2 = no. of patients in the study being compared to,
x1 = mean of the values of this study
x2 = mean of the values of the study being compared to
The mean IOP drop obtained in the eyes operated by 
Mercieca were compared to that of those reported in the study 
by Zacharia et al.2 On the other hand, the mean IOP post-op 
was compared to that of the study carried out by Casson et al.3 
Table 4 demonstrates the results obtained. It is important to 
note that the cohort of patients used in the study carried out 
by Zacharia, included black patients whose glaucoma is more 
difficult to control than that of caucasians.
In both cases, the t-analysis value is less than the standard 
values at the 5% level of significance. Thus we conclude that 
the difference in means between Mercieca’s and the respective 
studies is not significant.
Significance of difference in proportions
The formulae for the distribution of proportions used are: 
where
= no. of patients in this study
= no. of patients in the study being compared to 
= mean of the values of this study
= mean of the values of the study being compared to
r =  pooled proportion 
The proportion of eyes that developed hypotonicity in this 
study were compared to those in the studies carried out by 
Hyung et al 4 and Zacharia et al. 2 The incidence of development 
of maculopathy reported by Hyung et al was also compared to 
that reported in our patients. We also compared the results of 
surgery that was classified as a complete success with those 
reported by Megevand et al.5 The z value of this analysis and 
the z value provided from standard calculated tables depending 
on the degrees of freedom at the 5% level of significance are 
displayed in table 5.
These results show that the difference in proportions 
between results obtained in Mercieca’s patients and the 
respective studies is not significant.
Discussion
Compounds that modulate wound healing post-
trabeculectomy have been investigated in the hope of 
obtaining an increase in the success of glaucoma filtering 
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surgery.6 5-Fluorouracil was the first antimetabolite drug 
used in trabeculectomy to prevent scarring of the filtration 
bleb after glaucoma filtering surgery.7 Its use requires 
intraoperative application followed by a variable number of 
postoperative subconjunctival injections of 5 Fluorouracil in 
the trabeculectomy area. Consequent complications such as 
corneal epithelial defects, corneal opacification and conjunctival 
wound leaks discouraged its widespread use.26,27 In 1983, 
Chen8 reported that complications occurring with the use of 
5-fluorouracil, were encountered less frequently with MMC. 
Since then MMC has been primarily considered in the context of 
known risk factors for failure of trabeculectomy.22-25,28,29 Among 
the higher risk factors for surgery failure we find neovascular 
glaucoma, a previously failed trabeculectomy, and certain 
secondary glaucomas (e.g. inflammatory, post-traumatic angle 
recession and iridocorneal endothelial syndrome). Intermediate 
risk factors include the use of topical antiglaucoma medication 
for over 3 years, previous conjunctival surgery and previous 
cataract surgery.7, 9-15
Palmer 16 carried out a study which confirms that MMC 
as adjunct chemotherapy with trabeculectomy is effective in 
delaying progression of cupping or visual field loss. This was 
confirmed further by Hagiwara et al17 in 2000.
Most of the complications observed in this study seemed 
to be secondary to excessive filtration. 8 of the 32 eyes suffered 
from early hypotonicity and 1 suffered from late hypotonicity. 
3 eyes developed hypotonic maculopathy and 3 suffered from 
choroidals. None of the choroidal effusions that developed 
in our patients required surgical drainage. It is thought that 
hypotony leads to inward movement of the scleral wall, resulting 
in chorioretinal wrinkling, disc swelling and vascular tortuosity. 
18 The chorioretinal folds in the macular area and RPE changes 
seen in a later stage of the process are responsible for the 
visual acuity loss.19 Other clinical features include thickening 
of the cornea associated with striae at Descemet’s membrane, 
shallow anterior chamber, peripheral anterior synechiae, 
suprachoroidal haemorrhage and choroidal detachment. Both 
overfiltration because of tissue disorganization of the filtering 
bleb and aqueous hyposecretion because of ciliary body toxicity 
might be involved in the causes of persistent hypotony after 
using MMC. 
Zacharia et al 2 investigated the incidence of hypotony 
after trabeculectomy with MMC. Hypotony occured in one 
third of these eyes. They proved that there is a statistically 
significant association of hypotony with longer application time 
of mitomycin C. Subsequent retrospective comparative studies 
carried out by Mégevand, Salmon et al 5 found that a 2-minute 
application of 0.2 mg/ml MMC is as effective as a 5-minute 
exposure with the complication rate remaining unaltered. The 
optimum dose for a balance between utilizing the antimetabolite 
properties of MMC and preventing its serious complications is 
still under research. 
In 2003, Hyung and Jung 4 studied the management of 
hypotony after trabeculectomy with MMC. The following 
Figure 7: Complications occuring post-op
Figure 4: Early post-op IOP
Figure 5: IOP one year post-op
Figure 6: Percentage post-op intra-ocular pressure drop
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methods in a stepwise manner were applied: medical treatment, 
intrableb autologous blood injection, additional sutures to the 
scleral flap, necrotic bleb excision and advancement of the 
forniceal conjunctival flap. They also concluded that the most 
prevalent risk factors of hypotony were young age and primary 
open angle glaucoma. Thus one has to be cautious in the use 
of MMC for juvenile primary open angle glaucoma.20 Studying 
further patient variables that determine the fibrotic response 
and the susceptibility to hypotonous maculopathy would 
certainly help in the treatment of these challenging cases.
Limitations of data collection
Limitations of this study were mainly due to the retrospective 
nature of the analysis which limited us in the amount of 
information that was available. Data of four operations could 
not be retrieved. In two of the cases, not enough pre-operative 
or post-operative information was available since one patient 
was operated urgently with little pre-op information while the 
other was lost to follow up. In the other two cases, access to the 
data was not possible; one patient passed away, while, the other 
patient, was admitted in another hospital at the time the study 
was being carried out. Also, all the patients operated upon were 
all Caucasians. As such, the results of our study may not apply 
to patients from other ethnic backgrounds. 
Conclusion
The overall goal for all glaucoma treatment is to preserve 
useful vision. Glaucoma is a multifactorial disease but the 
intraocular pressure is still the only known treatable risk factor. 
Substantial pressure reduction is difficult to achieve without 
filtering surgery. Antiproliferatives have increased the odds of 
retaining the pressure reduction after filtering surgery, and as a 
result they have decreased the progression of visual field defects 
and optic nerve damage. In this analysis, 23 out of the 32 eyes 
operated upon were a complete success while 6 of the operated 
eyes were a partial success. With regards to complication rates, 
early hypotonicity is predominant, followed by hyphaema. 
Incidences obtained from this analysis compare very favourably 
with results from international studies. In fact, there were no 
significant differences in the trends and percentages regarding 
complications, IOP drop and control between results from our 
data and those from international studies.
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